secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2022-04-13T23:59:59+00:00
Accession:  0001645113-22-000037
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NovoCure director Sherilyn McCoy not standing for reelection at June 2022 annual meeting
--------------------------------------------------------------------------------

- Director Sherilyn McCoy informed NovoCure she will not stand for reelection at the June 8, 2022 annual meeting.
- Decision is not due to any disagreement with the company; she cites a desire to focus on other professional commitments.
- McCoy will continue to serve on the board until the expiration of her term at the annual meeting.
- NovoCure thanked McCoy for her service and significant contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/0001645113-22-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/nvcr-20220411.htm
  HTML page:      https://secwatch.observer/filing/0001645113-22-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer